Even though markets aren’t in crisis mode, investors have been piling into precious metals. Gold has climbed around 35% over the past year, reaching around $2,800 per ounce, while silver has posted ...

Fueled by powerful winds and dry conditions, a series of ferocious wildfires erupted the second week of January and roared ...

JPMorgan Chase's co-head of global markets, Jason Sippel, is leaving the Wall Street lender and Pranav Thakur has been named ...

JPMorgan Chase & Co. (NYSE: JPM) is rewarding its shareholders once again with a quarterly dividend of $1.25 per share, payable on Friday, Jan. 31. That is in line with the prior payout. The bank just ...

Meet the women investors who have made their mark by shaping the finance industry with their expertise and leadership.

The cannabis industry and its financial partners see potential gains under Trump, either in the form of direct changes in ...

Trump Media, the company that runs Donald Trump's social media platform Truth Social, is expanding into financial services ...

In particular, continued slow loan growth is becoming a drag on regional banks, which have less exposure to the booming Wall Street trading and investment-banking business that is ...

Thanks to the Chase Sapphire Reserve's generous perks, I earn my annual fee back several times over. Learn more and see if it ...

After a two-year gut renovation, 25 Water St., a former banking operations hub in the Financial District, has been reborn as ...

Tesla's earnings report and call Wednesday shed light on the electric vehicle maker's plans for new versions of its self-driving software and its humanoid robot, Optimus.

A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.